CMS should monitor the effect on Medicare standalone prescription drug plans of changes in how the drug costs of high-cost ...
The conference’s first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback